Wyeth’s Prevenar Vaccine Approved in Russia

LONDON, March 2 (Reuters) - Wyeth has won approval to sell its top-selling pneumococcal vaccine Prevenar in Russia and expects to launch the product there later this year, the U.S. drugmaker said on Monday.
MORE ON THIS TOPIC